Complex, chronic wounds are increasingly recognized as life-altering conditions with mortality rates rivaling or surpassing certain cancers. A new publication from JWC entitled "Application of a ...

MediWound Ltd. (NASDAQ: MDWD) Q3 2025 Earnings Call Transcript November 20, 2025 MediWound Ltd. beats earnings expectations.

Mediwound ( ($MDWD) ) has released its Q3 earnings. Here is a breakdown of the information Mediwound presented to its investors. MediWound Ltd., a ...

Observed annually on the third Thursday of November each year, Worldwide Pressure Injury Prevention Day serves as a global ...

The wound healing devices market is largely propelled by the growing incidence of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure sores, along with a rise in surgical ...

Powys Teaching Health Board has confirmed it has made a series of changes following the death of Edward Funnell, from Llandrindod Wells ...

The latest announcement is out from Mediwound ( (MDWD) ).

Ongoing Enrollment Continues in VALUE Phase III Trial of EscharEx® in Venous Leg Ulcers Commissioning Completed for Expanded NexoBrid® Facility; ...

Ongoing Enrollment Continues in VALUE Phase III Trial of EscharEx- in Venous Leg Ulcers Commissioning Completed for Expanded NexoBrid- Facility; Full Operational Capacity Expected by Year-End 2025 ...

Kure Care, a division of Veracor Group LLC, urges Medicare beneficiaries with chronic wounds to seek regenerative treatment before January 1, 2026 Medicare reimbursement changes. The company offers ...

Market, valued at approximately USD 37.9 million in 2023, is poised for sustained expansion, with a projected compound annual growth rate (CAGR) of 7.8% over the forecast period from 2024 to 2032.

PRNewswire/ - Medunik USA, a specialty pharmaceutical company, and part of Duchesnay Pharmaceutical Group (DPG), is dedicated to providing patients with rare diseases access to orphan drugs. Medunik ...